ASML vs PRLD · P/E 57, $665.37B cap vs rev $6.5M
ASML Holding NV ADR (ASML) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
ASML does not have a complete income-statement cache yet.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the ASML and PRLD stock pages for the full models.
Not investment advice.